Header Logo

Connection

Heather Feigelson to Genetic Testing

Back to Details
This is a "connection" page, showing publications Heather Feigelson has written about Genetic Testing.
Heather Feigelson
Connection Strength
0.988
Genetic Testing
  1. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med. 2013 Dec; 15(12):933-40.
    View in: PubMed
    Score: 0.215
  2. An Examination of the Ethical and Legal Limits in Implementing "Traceback Testing" for Deceased Patients. J Law Med Ethics. 2022; 50(4):818-832.
    View in: PubMed
    Score: 0.196
  3. Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample. PLoS One. 2014; 9(5):e94977.
    View in: PubMed
    Score: 0.115
  4. Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med. 2013 Sep; 15(9):721-8.
    View in: PubMed
    Score: 0.107
  5. Perception of direct-to-consumer genetic testing and direct-to-consumer advertising of genetic tests among members of a large managed care organization. J Genet Couns. 2012 Jun; 21(3):448-61.
    View in: PubMed
    Score: 0.098
  6. Improving Care for Marginalized Populations at Risk for Hereditary Cancer Syndromes: Innovations that Expanded Reach in the CHARM Study. Public Health Genomics. 2024; 27(1):16-22.
    View in: PubMed
    Score: 0.056
  7. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Res Treat. 2023 Oct; 201(3):461-470.
    View in: PubMed
    Score: 0.055
  8. Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. Cancer. 2022 Aug 15; 128(16):3090-3098.
    View in: PubMed
    Score: 0.050
  9. Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention. Breast Cancer Res. 2000; 2(4):277-82.
    View in: PubMed
    Score: 0.044
  10. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
    View in: PubMed
    Score: 0.026
  11. Utilization of HER2 genetic testing in a multi-institutional observational study. Am J Manag Care. 2012 Nov; 18(11):704-12.
    View in: PubMed
    Score: 0.026

© 2024 Kaiser Permanente